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Cai H, Wu L, Qu W, Malhotra D, Xie Z, Shapiro JI, Liu J.
Regulation of apical NHE3 trafficking by ouabain-induced activation of
the basolateral Na-K-ATPase receptor complex. Am J Physiol Cell
Physiol 294: C555–C563, 2008; doi:10.1152/ajpcell.00475.2007.—The
long-term effects of ouabain on transepithelial Na transport involve
transcriptional downregulation of apical Na/H exchanger isoform 3
(NHE3). The aim of this study was to determine whether ouabain
could acutely regulate NHE3 via a posttranscriptional mechanism in
LLC-PK1 cells. We observed that the basolateral, but not apical,
application of ouabain for 1 h significantly reduced transepithelial
Na transport. This effect was not due to changes in the integrity of
tight junctions or increases in the intracellular Na concentration.
Ouabain regulated the trafficking of NHE3 and subsequently inhibited
its activity, a process independent of intracellular Na concentration.
Ouabain-induced NHE3 trafficking was abolished by either choles-
terol depletion or Src inhibition. Moreover, ouabain increased the
intracellular Ca2 concentration. Pretreatment of cells with the intra-
cellular Ca2 chelator BAPTA-AM blocked ouabain-induced traf-
ficking of NHE3. Also, blockade of Na-K-ATPase endocytosis by
a phosphatidylinositol 3-kinase inhibitor was equally effective in
attenuating ouabain-induced NHE3 trafficking. These data indicate
that ouabain acutely stimulates NHE3 trafficking by activating the
basolateral Na-K-ATPase signaling complex. Taken together with
our previous observations, we propose that ouabain can simulta-
neously regulate basolateral Na-K-ATPase and apical NHE3, lead-
ing to inhibition of transepithelial Na transport. This mechanism
may be relevant to proximal tubular Na handling during conditions
associated with increases in circulating endogenous cardiotonic ste-
roids.
kidney; sodium; sodium/hydrogen exchanger isoform 3; trafficking;
c-Src; phosphatidylinositol 3-kinase
SODIUM/HYDROGEN EXCHANGERS (NHEs) are present in all mam-
malian cells. They are involved in regulating intracellular pH,
cellular volume, and cell growth. In the renal proximal tubule,
NHE3 and Na-K-ATPase are critical in transepithelial Na
reabsorption. We have previously reported that in LLC-PK1
cells (a widely accepted pig renal proximal tubule cell line),
exposure to low concentrations of ouabain (100 nM) for
12–24 h not only causes significant depletion of basolateral
Na-K-ATPase but also induces downregulation of NHE3
expression and activity. These regulations are dependent on the
ouabain-activated signaling function of Na-K-ATPase, and
they cause substantial inhibition of transepithelial 22Na trans-
port without affecting the intracellular Na concentration ([Na]i)
(33, 43).
Endogenous cardiotonic steroids, including ouabain and
marinobufagenin, are now accepted as a new class of steroid
hormones that are involved in blood pressure regulation and
renal Na handling (18, 19, 23, 26, 46). Elevated endogenous
ouabain levels have been found in a number of clinical condi-
tions that are associated with plasma volume expansion such as
chronic renal failure, hypertension, and congestive heart fail-
ure. The cardiotonic steroid binding site of Na-K-ATPase is
believed to be the same molecular target of the hypertensive
effects of these compounds, and this binding site appears to
play an important role in blood pressure regulation (18).
Na reabsorption in the proximal tubule involves the cou-
pling of apical Na entry via NHE3 and other transporters,
whereas basolateral Na extrusion occurs primarily through
Na-K-ATPase. Our previous observations have suggested
that the effects of endogenous cardiotonic steroids on NHE3
may represent an adaptive response to volume expansion, a
concept that resonates with early theories proposing the exis-
tence of one or more endogenous natriuretic compounds, as
introduced by Dahl et al. (13), Blaustein (8), and de Wardener
and Clarkson EM (14). It seems logical to propose that syn-
chronous regulation of Na-K-ATPase and NHE3 may
present a functional loop that regulates coordinated transepi-
thelial Na transport in this nephron segment.
NHE3 activity is controlled by phosphorylation, trafficking,
and transcriptional regulation. Regulated NHE3 trafficking has
been demonstrated in many cases that involve clathrin- and/or
lipid raft-dependent pathways (10, 31). Although the specific
mechanisms through which cardiotonic steroids affect NHE3-
mediated renal Na handling are still being elucidated, evi-
dence supports the notion that endogenous cardiotonic steroids
might cause a physiologically meaningful regulation of trans-
epithelial Na transport in the renal proximal tubule. NHE3
has been shown to be redistributed in hypertension, accompa-
nying reversible downregulation of Na-K-ATPase activity
in the renal cortex (56). In opossum kidney cells, overexpres-
sion of the Na-K-ATPase 1-subunit upregulated apical
NHE3 activity and abundance, resulting in the stimulation of
apical Na influx (20). Parathyroid hormone and dopamine
have been shown to stimulate endocytosis of Na-K-ATPase
and NHE3 (9, 11, 25, 27). Salt loading in vivo not only
significantly depressed NHE3 expression but also induced
Na-K-ATPase endocytosis in a marinobufagenin-dependent
manner (3, 44).
We have recently reported the mechanism through which
ouabain-induced transcriptional downregulation of NHE3 oc-
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curs. This results in decreased transepithelial Na transport.
Since we have shown that the activation of the basolateral
Na-K-ATPase/Src receptor complex by ouabain stimulated
endocytosis of Na-K-ATPase, we reasoned that this might
also regulate NHE3 trafficking so that apical NHE3 activity
can be coupled to the basolateral Na-K-ATPase activity to
keep intracellular Na homeostasis. To test this hypothesis, the
following experiments were conducted.
MATERIALS AND METHODS
Materials and cell culture. All chemicals, except otherwise men-
tioned, were obtained from Sigma (St. Louis, MO). Wortmannin,
protein phosphatase 2 (PP2), and 1,2 bis(2-aminophenoxy)ethane-
N,N,N,N-tetra-acetic acid-acetoxymethyl ester (BAPTA-AM) were
obtained from Calbiochem (San Diego, CA). 22Na was obtained
from DuPont NEN Life Science (Boston, MA).
A rabbit polyclonal antibody against a mixture of peptides from
porcine NHE3 was prepared and affinity purified (43). Horseradish
peroxidase-conjugated goat anti-rabbit IgG and antibodies against
early endosome antigen-1 (EEA1), Rab5, and Rab7 were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). Polyclonal anti-
bodies against occludin and claudin-1 were obtained from Zymed
Laboratories (San Francisco, CA). A monoclonal antibody against the
Na-K-ATPase 1-subunit (clone 6F) was obtained from the
Hybridoma Bank of the University of Iowa (Iowa City, IA).
The LLC-PK1 cell line was obtained from the American Type
Culture Collection (Manassas, VA) and cultured in DMEM containing
10% FBS, penicillin (100 U/ml), and streptomycin (100 g/ml) in a
5% CO2-humidified incubator. All cells were serum starved for 12 h
before experiments.
Measurements of intracellular Na and Ca2 concentrations.
[Na]i and intracellular Ca2 concentration ([Ca2]i) were measured
using a computer-controlled spectrophotometer (PTI, London, ON,
Canada) with Felix software (PTI) as previously described (36, 43).
Perfusion was set at a rate of 1 ml/min with a corresponding physi-
ological salt solution. For [Na]i measurements, LLC-PK1 cells were
loaded with 10 M of the Na-sensitive fluorescent dye SBFI-AM
(Molecular Probes, Eugene, OR) in the presence of 0.2% pluronic
F-127 (Molecular Probes) in physiological salt buffer [containing (in
mM) 110 NaCl, 3 KCl, 10 HEPES, 5 D-glucose, 1 CaCl2, 1.2 MgSO4,
1 NaHCO3, and 1 KH2PO4, with pH7.4 adjusted with Tris]. Fluores-
cent emissions were monitored at 510 nm to obtain excitation ratios
(F340/F380) by dual excitations at 340/380 nm. Calibration was per-
formed in situ with known concentrations of Na in the presence of
5 M of Na ionophore gramicidins and 10 M monensin (17). For
[Ca2]i measurements, LLC-PK1 cells were loaded with 2 M of the
Ca2-sensitive fluorescent dye fura-2-AM (Molecular Probes) in
physiological salt buffer [containing (in mM) 100 NaCl, 4 KCl, 20
HEPES, 10 D-glucose, 1 CaCl2, 1.2 MgCl2, 25 NaHCO3, and 1
NaH2PO4; pH7.4], and fura-2 fluorescent emissions were monitored
at 510 nm to obtain excitation ratios (F340/F380) by dual excitations at
340/380 nm. [Ca2]i was calculated based on the fluorescence ratio
and the in situ Ca2calibration using Ca2 ionophore ionomycin and
the extracellular Ca2 chelating agent EGTA.
NHE3 activity and active transepithelial 22Na transport. The
intracellular pH recovery rate and 22Na uptake were determined as
previously described (43). Calibration of intracellular pH was per-
formed using high-K-nigericin (10 M) standards (41). During
measurements of intracellular pH and 22Na uptake, 50 M amiloride
was used to inhibit amiloride-sensitive NHE1 activity. To measure
active transepithelial 22Na flux, a transepithelial 22Na transport
assay was performed in LLC-PK1 monolayers (grown on Costar
Transwell culture filter inserts, filter pore size: 0.4 m, Costar,
Cambridge, MA). LLC-PK1 monolayers were first treated with or
without ouabain (100 nM) applied in the basolateral or apical com-
partment, and active transepithelial 22Na flux (apical to basolateral)
was determined by counting radioactivity in the basolateral aspect at
1 h after 22Na addition.
Western blot analysis. Whole cell lysates were prepared using
ice-cold RIPA buffer [containing 1% Nonidet P-40, 0.25% sodium
deoxycholate, 150 mM NaCl, 50 mM Tris HCl (pH 7.4), 1 mM
EDTA, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM NaF, 10
g/ml aprotinin, and 10 g/ml leupeptin]. Cell lysates were then
centrifuged (4°C, 16,000 g, 10 min), and equal amounts of total
protein from the supernatants were used for Western blot analysis.
The membrane fraction was isolated as previously described (15)
using nondetergent membrane buffer (same as RIPA buffer but
without Nonidet P-40 and sodium deoxycholate). Cells were col-
lected, homogenized, and microfuged (4°C, 16,000 g, 10 min) to
remove insoluble cell debris and unbroken cells. Supernatants were
further centrifuged (109,000 g at the maximum radius for 30 min at
4°C), and pellets were resuspended in 1 Laemmli sample buffer. For
the Western blot analysis, equal amounts of total protein were re-
solved by 10% SDS-PAGE and immunoblotted with antibodies
against NHE3, the Na-K-ATPase 1-subunit, occludin, or clau-
din-1. The same membrane was stripped and immunoblotted with
anti-tubulin antibody to serve as an internal loading control. Signal
detection was performed with an enhanced chemiluminescence super
signal kit (Pierce, Rockford, IL). Multiple exposures were analyzed to
assure that the signals were within the linear range of the film. The
signal density was determined using Molecular Analyst software (Bio-
Rad, Hercules, CA).
Labeling of cell surface proteins by biotinylation. Cell surface
protein biotinylation was performed as previously described (22, 33).
LLC-PK1 cells were grown to form monolayers (6–7 days) on 24-mm
polycarbonate Transwell culture filter inserts (filter pore size: 0.4 m,
Costar). The culture medium was replaced daily until 12 h before
experiments, at which point the monolayer was serum starved. After
surface biotinylation with EZ-Link sulfo-NHS-ss-Biotin (Pierce) and
immobilization with ImmunoPure immobilized streptavidin-agarose
beads (Pierce), biotinylated proteins were eluted by an incubation in
a 55°C water bath for 30 min with an equal volume of 2 Laemmli
sample buffer, resolved by 10% SDS-PAGE, and then immuno-
blotted.
Isolation of early and late endosomes. Early and late endosomes
were fractionated on a flotation gradient using the technique of Gorvel
et al. (21). Early and late endosome fractions were identified with
antibodies against EEA1 and Rab5 (early endosome marker proteins)
as well as Rab7 (late endosome marker protein). The method has been
verified as we have previously described (33). For each sample or
treatment, LLC-PK1 cells were grown on three 150-mm dishes and
subjected to endosomal isolation.
Cholesterol depletion and repletion. Methyl--cyclodextrin (M-
CD; Sigma) was dissolved in DMEM and used directly as previously
described (50). Cholesterol depletion was carried out by incubating
the cells in the presence of 10 mM M-CD for 30 min at 37°C. Cells
were washed twice with serum-free medium before experiments.
Cholesterol repletion was carried out by incubating cholesterol-de-
pleted cells with DMEM containing 4% (vol/vol) cholesterol-M-CD
stock solution for 1 h at 37°C. Cholesterol-M-CD stock solution was
prepared by mixing 200 l of cholesterol (20 mg/ml in ethanol) with
10 ml of 10% M-CD solution by vortexing at 40°C.
Immunofluorescence microscopy. Immunofluorescence and confo-
cal microscopy were performed as previously described (33). LLC-
PK1 monolayers grown on Transwell filters were fixed in chilled
(20°C) methanol (100%), permeabilized for 15 min with permeabi-
lization buffer (0.3% Triton X-100 and 0.1% BSA in PBS with 0.1
mM CaCl2 and 1 mM MgCl2), and blocked for 30 min with blocking
buffer [containing 150 mM NaCl and 20 mM sodium phosphate
(pH7.4) with 0.3% Triton X-100 and 16% (vol/vol) normal goat or
horse serum]. Cells were incubated with primary antibodies (anti-
occludin or anti-claudin-1, 1:50 in blocking buffer) overnight at 4°C
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and washed three times with permeabilization buffer. Cells were then
incubated with Alexa fluor 488-conjugated secondary antibody (1:100
in blocking buffer, Molecular Probes) for 1 h at room temperature,
washed three times with permeabilization buffer, mounted in Prolong
Antifade mounting medium (Molecular Probes), and dried in the dark
overnight at room temperature. Confocal images were captured by a
Leica TCS SP2 spectral confocal scanner and a Leica DMIRE2
microscope (Leica, Mannheim, Germany) equipped with a 63 oil-
immersion objective. Visualization and analysis were performed using
Leica confocal microscope system software.
Statistical analysis. Data were tested for normality (all data passed)
and then subjected to parametric analysis. When more than two
groups were compared, one-way ANOVA was performed prior to
comparison of individual groups with an unpaired t-test. Bonferroni’s
correction for multiple comparisons was employed as appropriate.
Statistical significance was reported at the P  0.05 and P  0.01
levels. SPSS software was used for all analysis (SPSS, Chicago, IL).
RESULTS
Ouabain induces inhibition of NHE3 activity in LLC-PK1
cells. We have shown that ouabain stimulates endocytosis of
basolateral Na-K-ATPase in LLC-PK1 cells (33). Over
12–24 h, ouabain reduced NHE3 mRNA and protein expres-
sion (43), leading to significantly reduced transepithelial Na
transport in LLC-PK1 monolayers without altering [Na]i.
Since 100 nM ouabain failed to increase intracellular Na, a
balance of Na influx and efflux was expected. We assessed
the acute effect of low concentrations of ouabain on NHE3
activity by measuring Na-dependent intracellular pH recov-
ery and H-driven 22Na uptake. For these measurements,
LLC-PK1 cells were grown to confluence on glass coverslips
or 12-well plates, serum starved for 12 h, and then treated with
or without ouabain (100 nM) for different intervals. These
assays were performed in the presence of 50 M amiloride to
inhibit NHE1 activity. To determine H-driven Na uptake,
cells were first acid loaded in Na-free buffer with 20 mM
NH4Cl and then assayed for 22Na uptake. Ouabain (100 nM)
treatment significantly decreased H-driven 22Na uptake in a
time-dependent manner (Fig. 1A). To determine if ouabain-
induced decreases in 22Na uptake were due to the inhibition
of NHE3 activity, the Na-stimulated pH recovery rate after
Na reintroduction was also determined. After ouabain treat-
ment (100 nM, 1 h), the Na-stimulated pH recovery rate was
also decreased by 	30% (0.22 
 0.04 pH units/min, n  8)
compared with control cells (0.32 
 0.05 pH units/min, n  8,
P  0.01; Fig. 1B). To evaluate the acute ouabain effect on
transepithelial Na transport, LLC-PK1 cells were grown on
Transwell filters to form monolayers. Ouabain (100 nM, 1 h)
was applied to the basolateral or apical aspect, and transepi-
Fig. 1. Ouabain (Oua) inhibits Na/H exchanger isoform 3 (NHE3) activity
and transepithelial 22Na transport. LLC-PK1 cells were treated with or
without 100 nM ouabain for the indicated times. H-driven 22Na uptake,
Na-dependent intracellular pH recovery, transepithelial 22Na transport, and
intracellular Na concentration ([Na]i) were measured as described in MA-
TERIALS AND METHODS. A: H-driven 22Na uptake after ouabain (100 nM)
treatment (n  6). B: Na-dependent intracellular pH recovery after ouabain
(100 nM, 1 h) treatment (n  8). C: effects of ouabain (100 nM, 1 h) treatment
on transepithelial 22Na transport (n  6). Ouabain was applied in the
basolateral (Baso) or apical aspect of LLC-PK1 monolayers grown on Trans-
well filter supports. D: effects of ouabain (100 nM) treatment on [Na]i (n 
12). For bar graphs, values are means 
 SE and are expressed relative to the
control. **P  0.01, ouabain treatment vs. control.
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thelial 22Na flux (from apical to basolateral compartments)
was determined. Ouabain treatment in the basolateral aspect
significantly reduced transepithelial 22Na flux, but no such
effect was observed with apical exposure to ouabain (n  6;
Fig. 1C). Since high concentrations of ouabain have been
shown to increase [Na]i, depolarize proximal tubule cells, and
affect the tight junction integrity of epithelial cells (6, 42, 45),
we further evaluated if low concentrations of ouabain have any
acute effects on [Na]i and tight junctions. In LLC-PK1 cells,
real-time [Na]i measurements did not show any significant
[Na]i change in response to ouabain (100 nM; Fig. 1D).
However, [Na]i was significantly increased in response to
high concentrations of ouabain (10 and 100 M, 30 min; data
not shown). In LLC-PK1 monolayers, a low concentration of
ouabain (100 nM) did not show any effect on transepithelial
electrical resistance (45). Consistently, low concentrations of
ouabain have no discernable effects on tight junctions. Ouabain
(100 nM for 1 h and up to 6 h) did not alter the expression
(Fig. 2A) or distribution of two tight junction proteins, occludin
(Fig. 2, B and C) and claudin-1 (data not shown). In contrast,
when LLC-PK1 monolayers were washed and incubated in
Ca2-free (with 1 mM EDTA) medium for 5 min before being
immunostained for occludin, some broken tight junctions (de-
fined as loss of tight contact of plasma membrane between two
adjacent cells) could be demonstrated (Fig. 2D).
The present data are consistent with the notion that ouabain-
induced inhibition of NHE3 activity is due to the effect(s) of
ouabain on basolateral Na-K-ATPase, which regulates both
ion transporters to maintain intracellular Na homeostasis.
Ouabain-induced NHE3 trafficking leads to the inhibition of
NHE3 activity in LLC-PK1 cells. The observed acute change in
NHE3 activity is most likely due to an alteration in NHE3
trafficking, because ouabain had no acute effect on NHE3
mRNA or total NHE3 protein expression up to 6 h (data not
shown). To determine if ouabain could regulate NHE3 traf-
ficking, we examined the distribution of NHE3 on the cell
surface and in endosomes in response to ouabain.
After LLC-PK1 cells were treated with or without ouabain
(100 nM, 1 h), whole cell lysates and membrane fractions were
prepared and analyzed by Western blot. Tubulin served as the
loading control. As shown in Fig. 3, whereas chronic ouabain
treatment (100 nM, 12 h) significantly reduced NHE3 expres-
sion in whole cell lysates (43), acute ouabain treatment (100
nM, 1 h) had no effect on NHE3 protein content in whole cell
lysates (P  0.05, n  6; Fig. 3A), but it significantly reduced
NHE3 content in membrane fractions (P  0.01, n  6; Fig.
3B). These observations were further confirmed by cell surface
biotinylation experiments, which showed a significant decrease
in cell surface NHE3 protein content in response to ouabain
(100 nM, 1 h) added to the basolateral but not apical compart-
ment (P  0.01, n  4; Fig. 3C). The observed decrease in
NHE3 protein abundance in cell surface and membrane frac-
tions, but not in whole cell lysates, suggests a redistribution of
NHE3 in response to acute ouabain treatment. Under these
conditions, the Na-K-ATPase 1-subunit was also redistrib-
uted in the same pattern as seen in NHE3 (data not shown),
consistent with our early observation (33).
In addition to cell surface biotinylation, early and late
endosomes were isolated to explore the redistribution status of
NHE3. Early and late endosomes were isolated and identified
with anti-EEA1, Rab5, and Rab7 antibodies. Ouabain (100 nM,
1 h) treatment significantly accumulated NHE3 protein in early
endosomes (P  0.01, n  9; Fig. 4). Interestingly, the
Na-K-ATPase 1-subunit was also accumulated and coex-
isted with NHE3 in the same early endosome preparation in
response to ouabain (P  0.01, n  9; Fig. 4). It is important
to note that the accumulation of both proteins in the early
Fig. 2. Ouabain has no significant effect on the integrity of tight junctions in
LLC-PK1 monolayers. LLC-PK1 monolayers were treated with or without 100
nM ouabain for 1 h. The abundance of occludin and claudin-1 in whole cell
lysates were measured by Western blot analysis; tubulin served as a loading
control. Occludin distribution was imaged with confocal microscopy after
fluorescence immunostaining. A: representative Western blot showing the
abundance of occludin and claudin-1 in whole cell lysates. No significant differ-
ences were observed (P  0.05, ouabain vs. control; n  3). B–D: distribution of
occludin in LLC-PK1 monolayers under control conditions (B), with ouabain
treatment (C), and after preincubated in Ca2-free medium for 5 min (D). The
arrow shows a disrupted tight junction. Bars  15 m.
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endosomes appears to occur simultaneously, indicating co-
ordinated regulation of both ion transporters by ouabain.
Under these conditions, the Na-K-ATPase 1-subunit
was also accumulated in late endosomes, but no detectable
NHE3 protein was observed in late endosomes (data not
shown).
Activation of the basolateral Na-K-ATPase/Src receptor
complex is required for ouabain-induced trafficking of NHE3.
Since 100 nM ouabain had no effect on [Na], it is less likely
that changes in [Na]i are responsible for ouabain-induced
trafficking of NHE3. To further investigate the effect of [Na]i
on the ouabain-induced regulation of NHE3, an equilibrium of
[Na]i with the extracellular Na concentration was achieved
using conventional “Na-clamping” methods in LLC-PK1
cells (24). LLC-PK1 cells were pretreated with either 20 M
monensin or 10 M monensin plus 5 M gramicidins for 30
min. Under both conditions, basal levels of NHE3 protein
content in early endosomes were significantly increased, but
ouabain (100 nM, 1 h) was still able to induce significant
accumulation of NHE3 in early endosomes, as observed in
normal control medium (Fig. 5). Again, under the same Na-
clamping conditions, ouabain also accumulated the Na-K-
ATPase 1-subunit in the same early endosome fraction (data
not shown). These observations indicate that ouabain-induced
trafficking of both NHE3 and Na-K-ATPase is independent
of [Na]i.
In LLC-PK1 cells, ouabain triggers signaling cascades in-
volving the activation of c-Src kinase and phosphatidylinositol
3-kinase (PI3K), through the caveolar Na-K-ATPase/Src
signaling complex. These cascades are critical in ouabain-
induced endocytosis of Na-K-ATPase and transcriptional
regulation of NHE3 (33, 34, 43). In epithelial cells, lipid rafts
and/or caveolae appear to play important roles in the trafficking
of Na-K-ATPase and NHE3 (31, 34, 40). To determine the
role of caveolae and/or lipid rafts in the ouabain-induced
trafficking of Na-K-ATPase and NHE3, caveolae and/or
lipid rafts were disrupted and reestablished by cholesterol
depletion (using M-CD) and repletion. Disruption of caveolae
and/or lipid rafts by cholesterol depletion prevented the
ouabain-induced accumulation of NHE3 in early endosomes,
Fig. 4. Ouabain accumulates NHE3 in early endosomes (EEs) but not in late
endosomes (LEs). LLC-PK1 cells were treated with or without 100 nM
ouabain for 1 h. EEs and LEs were isolated and identified as described in
MATERIALS AND METHODS. The abundance of NHE3 and the Na-K-ATPase
1-subunit was detected by Western blot. No detectable NHE3 protein was
observed in LEs. The Na-K-ATPase 1-subunit also accumulated in LEs
(data not shown). Values are means 
 SE and are expressed relative to the
control. **P  0.01, ouabain treatment vs. control (n  9).
Fig. 3. Ouabain causes NHE3 redistribution in LLC-PK1 cells. A: represen-
tative Western blot of whole cell lysates before and after ouabain treatment
(100 nM; bottom) and bar graph summary of the immunoblotting data (n  6;
top). B: representative Western blot of membrane-associated NHE3 protein
abundance before and after ouabain treatment (100 nM, 1 h; bottom) and bar
graph summary of the immunoblotting data (n  6; top). C: representative
Western blot of cell surface NHE3 as detected by cell surface protein
biotinylation before and after ouabain treatment (100 nM, 1 h; bottom) and bar
graph summary of the immunoblotting data (n 4; top). For bar graphs, values
are means 
 SE and are expressed relative to the control. **P  0.01, ouabain
treatment vs. control.
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and cholesterol repletion restored the endosomal accumulation
of NHE3 (Fig. 6). Under the same conditions, the ouabain-
induced accumulation of Na-K-ATPase was also prevented
by cholesterol depletion and restored by repletion (data not
shown and Ref. 34). Moreover, M-CD pretreatment also
significantly prevented the effect of ouabain on NHE3-medi-
ated H-driven 22Na uptake (data not shown). To determine
the effects of Src kinase and/or PI3K, LLC-PK1 cells were
preincubated with a specific inhibitor of c-Src (1 M PP2) or
PI3K (100 nM wortmannin) for 30 min and then treated with
ouabain (100 nM, 1 h) in the presence of the inhibitor.
Inhibition of c-Src or PI3K prevented not only the ouabain-
induced downregulation of NHE3 activity (H-driven 22Na
uptake; Fig. 7A) but also ouabain-induced NHE3 trafficking
(determined by cell surface biotinylation; Fig. 7B). PP2 or
wortmannin alone did not show any effect. These observations
indicate that ouabain-mediated NHE3 regulation is triggered
by the ouabain-activated basolateral Na-K-ATPase/Src re-
ceptor complex.
Intracellular Ca2 is a potential “second messenger” in the
ouabain-induced regulation of NHE3. Since ouabain inhibits
transepithelial Na transport via a simultaneous regulation of
the two transporters without changing [Na]i, ouabain-acti-
vated basolateral signaling has to be “moved” from the baso-
lateral aspect to the apical aspect. Ca2 signaling is involved in
the control of Na handling in renal epithelial cells. Binding of
ouabain to Na-K-ATPase has been shown to activate a
[Ca2]i oscillatory signaling pathway in epithelial cells that is
independent of changes in [Na]i (1). These findings led to the
speculation that Ca2 signaling may be important in the
ouabain-induced regulation of NHE3. Indeed, we observed that
ouabain (100 nM) significantly increased [Ca2]i in LLC-PK1
cells in normal culture medium (Ca2  1 mM), from 112.5

18.9 to 236.6 
 21.8 nM (n  12, P  0.01), within 15 min.
Pretreatment of LLC-PK1 cells with 10 M BAPTA-AM, a
membrane-permeable Ca2 chelator, did not change basal
[Ca2]i levels but attenuated ouabain-induced increases in
[Ca2]i (131 
 16.9% with BAPTA-AM vs. 210 
 18.8% in
control, n  9, P  0.01). Consequently, it also attenuated
ouabain-induced cell surface depletion and endosomal accu-
mulation of NHE3 (Fig. 8). This supports the notion that
ouabain-activated Ca2 signaling may be a potential second
messenger in the ouabain-induced regulation of NHE3.
DISCUSSION
In the renal proximal tubular cell, NHE3 is expressed in the
apical membrane, playing a pivotal role in transepithelial Na
reabsorption (2, 7, 47). Na-K-ATPase resides at the baso-
lateral surface, providing the driving force for the active
vectorial transport of Na from the tubular lumen to the
vascular compartment. In addition to ion pumping, Na-K-
ATPase also functions as a receptor and signal transducer (52).
Although Na-K-ATPase itself lacks tyrosine kinase activity,
Na-K-ATPase and Src assemble into a functional receptor
complex in the caveolae microdomain, which is capable of
converting the extracellular ouabain signal to the activation of
various signaling cascades (49, 50). As part of this Na-K-
ATPase signaling process, ouabain also induces clathrin-de-
pendent endocytosis of Na-K-ATPase. This process re-
quires caveolin-1 and the activation of c-Src kinase and PI3K
(33, 34). In renal epithelial cells, low concentrations of ouabain
Fig. 6. Depletion of cholesterol prevents the ouabain-induced accumulation of
NHE3 in EEs. Cholesterol depletion [using methyl--cyclodextrin (M-CD)]
and repletion (Rep) were performed as described in MATERIALS AND METHODS.
After cholesterol depletion and repletion, LLC-PK1 cells were treated with
ouabain (100 nM) for 1 h, and EEs were isolated. The abundance of NHE3 was
determined by Western blot. Values are means
 SE and are expressed relative
to the control. **P  0.01 ouabain treatment vs. control (n  4).
Fig. 5. Ouabain-induced endocytosis of Na-K-ATPase and NHE3 is inde-
pendent of [Na]i. LLC-PK1 cells were pretreated with either 20 M monen-
sin (M) or 10 M monensin plus 5 M gramicidins (M  G) for 30 min to
equilibrate [Na]i with the extracellular Na concentration. LLC-PK1 cells in
normal medium were used as controls. Cells were then treated with or without
100 nM ouabain for 1 h. The abundance of NHE3 in EEs is shown.
A: representative Western blot; B: bar graph summary of the immunoblotting
data. Similar results were also observed for the Na-K-ATPase 1-subunit
(data not shown). Values are means 
 SE and are expressed relative to the
control in normal medium. **P  0.01, ouabain treatment vs. control; #P 
0.01, ouabain treatment vs. control with monensin or monensin plus gramici-
dins (n  4).
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chronically reduce transepithelial Na transport without a
concomitant rise in [Na]i (43). While our initial investigations
of this phenomenon demonstrated that ouabain-activated Na-
K-ATPase/Src signaling led to the transcriptional downregu-
lation of NHE3, we could not exclude a possible acute effect
on NHE3 activity that would be necessary to effect acute
changes in transepithelial Na transport. The present study
aimed to examine whether such acute effects could be demon-
strated.
Our results suggest that acute exposure of LLC-PK1 cells to
ouabain significantly inhibited transepithelial Na transport by
simultaneously stimulating endocytosis of basolateral Na-
K-ATPase and apical NHE3. This process is most likely
triggered by the ouabain-activated Na-K-ATPase/Src recep-
tor complex in the caveolae microdomain. Ouabain seems to
have biphasic effects on NHE3 regulation; acutely it stimulates
NHE3 trafficking and chronically it inhibits NHE3 expression.
In both processes, ouabain-activated signaling plays a central
role. First, ouabain treatment significantly reduced transepithe-
lial Na transport without altering [Na]i. These effects were
only observed with ouabain treatment on the basolateral aspect,
but not on the apical aspect, suggesting that the reduced apical
Na entry is triggered at the basolateral membrane. Second,
equilibrium of Na across the membrane by Na clamping did
not prevent ouabain-induced early endosomal accumulation of
NHE3 and Na-K-ATPase. Third, the ouabain effects on
NHE3 activity and transepithelial Na transport were blocked
by c-Src and PI3K inhibitors. Moreover, whereas caveolin-1
was required in the ouabain-induced transcriptional regulation
of NHE3 and endocytosis of Na-K-ATPase, caveolae/lipid
rafts were also involved in ouabain-induced NHE3 trafficking.
At this point, we cannot conclude if NHE3 activity is closely
related to the cell surface NHE3 protein content, since NHE3
activity may also be regulated through its kinetic properties
[Vmax, KNa, and K(H)i] (30, 40). Even though we demonstrated
a net decrease in cell surface NHE3 with a concomitant net
accumulation of NHE3 in early endosomes, it is important to
note that ouabain may also affect NHE3 exocytosis or recy-
cling in this phenomenon. Since the isolated early endosomes
may also contain recycling vesicles, accumulation of NHE3 in
the early endosomal vesicles cannot be used as the only
evidence for increased endocytosis. These issues remain to be
resolved experimentally. We also noted that, in response to
acute hypertension and parathyroid hormone treatment, NHE3
was redistributed to the base of microvilli but not to endosomes
in the rat proximal tubule (53); however, cultured proximal
tubule-derived cell lines lack microvilli and the intermicrovil-
lar cleft structures found in the brush border of proximal
tubules in situ (37). This may account for the differences
observed in cultured cells.
It is well documented that ouabain-activated Ca2 signaling
pathways are independent of [Na]i changes. In cells express-
ing Na-K-ATPase 2/3-subunits, ouabain induces Ca2
transients without the induction of bulk changes in [Na]i or
modulates local increases in [Na]i and [Ca2]i via store-
operated Ca2 channels and the Na/Ca2 exchanger (4, 5). In
cells expressing only the Na-K-ATPase 1-subunit, like
LLC-PK1 cells and other kidney cells, ouabain-induced Ca2
oscillation signaling is also independent of [Na]i (1, 39).
Fig. 7. c-Src and phosphatidylinositol 3-kinase (PI3K) are involved in the
ouabain-induced NHE3 endocytosis and inhibition of NHE3 activity. LLC-
PK1 cells were pretreated with a c-Src specific inhibitor (PP2; 1 M, 30 min)
or the PI3K-specific inhibitor wortmannin (Wort; 100 nM, 30 min) followed by
ouabain treatment (100 nM, 1 h) in the continued presence of the respective
inhibitor. A: H-driven 22Na uptake in response to ouabain and inhibitors
(n  4). B: abundance of cell surface NHE3 in response to ouabain and
inhibitors (n  4). Values are means 
 SE and are expressed relative to the
control. **P  0.01, ouabain treatment vs. control.
Fig. 8. Involvement of intracellular Ca2 in ouabain-induced NHE3 endocy-
tosis. LLC-PK1 cells were pretreated with 10 M BAPTA-AM for 30 min and
then treated with or without 100 nM ouabain for 1 h. Surface NHE3 was
detected by surface biotinylation, and early endosomal NHE3 was detected by
endosome isolation following Western blot analysis. Values are means 
 SE
and are expressed relative to the control treatment. **P  0.01, ouabain
treatment vs. control (n  4).
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These data indicate that ouabain may function differently
depending on the cell type and isoform. Interestingly, the
binding of ouabain to Na-K-ATPase not only tethers
PLC-1 and the inositol 1,4,5-trisphosphate receptor (IP3R)
together to form a Ca2-regulatory complex (54) but also
stimulates the interaction of the NH2 terminus of the endoplas-
mic reticulum-localized IP3R with the NH2 terminus of the
Na-K-ATPase -subunit (55). These observations support
the notion that ouabain-activated Na-K-ATPase signaling
may also regulate NHE3 in the renal proximal tubule, since
intracellular Ca2 has been shown to regulate NHE3 activity
and trafficking (16, 29).
Our observations also raise an interesting question: how
does ouabain-activated basolateral Na-K-ATPase/Src sig-
naling regulate apical NHE3? Except for the role in Ca2
signaling, it is reasonable to propose that ouabain-activated
Na-K-ATPase signaling or endocytosed ouabain-Na-K-
ATPase might serve as a “coupling point” in the regulation of
transepithelial Na transport (32). Receptor-mediated endocy-
tosis has been shown not only to attenuate ligand-activated
signaling but also to continue the signaling on the endocytic
pathway, especially from endosomes (38, 48). Endocytic re-
ceptor tyrosine kinase (RTK) receptors could control the mag-
nitude of the original signaling response (generated at the cell
surface) or initiate distinct signaling cascades (qualitatively
different from that generated at the cell surface) (51). In
polarized epithelial cells, distribution of RTK substrates could
affect cellular responses (28). The endosomal signaling ap-
pears to be dependent on both the receptor and cell type. In
LLC-PK1 cells, ouabain not only induced compartmentaliza-
tion of Na-K-ATPase, c-Src, EGF receptor, and ERK in
early endosomes (33) but also bound to Na-K-ATPase
along the endocytic route (12, 35). Interestingly, caveolin-1 is
also present in early or recycling endosomes. These facts make
it possible that endosomal ouabain-Na-K-ATPase might be
able to propagate its original signaling or to initiate distinct
signaling cascades. This is supported by our findings that
ouabain-induced NHE3 regulation is mediated by the activa-
tion of the receptor function of Na-K-ATPase. Furthermore,
endocytosis is required for ouabain to remove basolateral
Na-K-ATPase, which induces significant inhibition of the
pumping activity. Moreover, blockade of Na-K-ATPase
endocytosis appears to be sufficient to abolish ouabain-induced
trafficking and transcriptional regulation of NHE3.
Although more work will be required to delineate the mech-
anism (like the role of NHE regulatory factor, NHE3 phos-
phorylation, and Ca2 signaling), the data presented here
provides new evidence for the cardiotonic steroid-mediated
regulation of transepithelial Na transport in the renal proxi-
mal tubule. This may represent an underlying mechanism of
cardiotonic steroid-mediated renal adaptation to volume expan-
sion and/or hypertension. In this process, it is logical to
propose that ouabain-activated Na-K-ATPase signaling
(from the cell surface and/or endosomes) may regulate Na
handling via synchronous regulation of both basal and apical
ion transporters, but the role of endocytic ouabain-Na-K-
ATPase and Ca2 signaling in ouabain-induced NHE3 regula-
tion remains unresolved.
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